Patricia L. Allen, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 49,300 shares at $65.93 ($3.3M) on 2020-01-24, disclosed to the SEC on 2020-01-28.
Open-market sale of $3.3M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.93 | 17,804 | $1.2M | 36.0% |
| 2 | $65.93 | 17,804 | $1.2M | 36.0% |
| 3 | $66.55 | 6,496 | $432K | 13.3% |
| 4 | $66.55 | 6,496 | $432K | 13.3% |
| 5 | $67.36 | 700 | $47K | 1.4% |
| Total | $66.11 avg | 49,300 |
| $3.3M |
| 100% |
| Filing → |
| ZFGN | BUY | 2016-07-26 | $50K | — | Filing → |
| ALNY | SELL | 2009-04-24 | $441K | — | Filing → |
| ALNY | SELL | 2007-10-26 | $440K | — | Filing → |